首页> 外国专利> METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS

METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS

机译:在患者冠状动脉肾脏移植功能预后中评估尿中性核糖核酸酶相关脂质体(uNGAL)的方法,包括对患者进行移植物延迟诊断(DGF)的诊断,一种评估疼痛的方法经早期移植功能(EGF)诊断的患者及相关套件

摘要

A method of prognosticating cadaveric kidney transplant function in a patient; a method of prognosticating cadaveric kidney transplant function in a patient diagnosed with DGF; a method of assessing risk of DGF in a patient, who has been diagnosed with EGF; and a kit comprising at least one component for assaying urine from a patient for NGAL and instructions for assaying the urine for NGAL and assessing cadaveric kidney transplant function or risk of DGF in the patient.
机译:一种对患者尸体肾移植功能进行预后的方法;在诊断为DGF的患者中对尸体肾移植功能进行预后的方法;一种评估被诊断患有EGF的患者DGF风险的方法;试剂盒,其包含至少一种用于分析来自患者的尿液中的NGAL的成分以及用于分析所述尿液中的NGAL的说明以及评估患者的尸体肾移植功能或DGF风险的说明。

著录项

  • 公开/公告号US2011229921A1

    专利类型

  • 公开/公告日2011-09-22

    原文格式PDF

  • 申请/专利权人 ROBERT C. DOSS;SUDARSHAN HEBBAR;

    申请/专利号US20100796794

  • 发明设计人 ROBERT C. DOSS;SUDARSHAN HEBBAR;

    申请日2010-06-09

  • 分类号C12Q1/37;

  • 国家 US

  • 入库时间 2022-08-21 18:14:35

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号